In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medical Device and In Vitro Diagnostics Deal Statistics Quarterly, Q3 2007

Executive Summary

In this issue, we present another installment of our quarterly review of medical device and in vitro diagnostics/research dealmaking-for July-September 2007. Our data are derived from Windhover's Strategic Transactions Database.

You may also be interested in...



Start-Up Quarterly Statistics, Q4 2007

Start-Up analyzes fundraising and alliances among start-ups in the biopharmaceutical, medical device and in vitro diagnostics segments from October through December 2007. Data is derived from Windhover’s Strategic Transactions Database.

Medco: Market Multiplier for Personalized Medicine

Medco is developing data that could accelerate the adoption of personalized medicine--as a way to make itself more relevant to customers and the lives they represent. Armed with infrastructure from its mail pharmacy business and access to medical information on large groups of people, it is financing and conducting studies to show the value of pharmacogenomic tests in improving clinical outcomes. By so doing, it could become an incredible enabler of companies pursuing personalized medicine.

JenaValve Technology GMBH

JenaValve is developing percutaneous aortic valve replacement technology for high-risk patients with severe aortic stenosis. Its self-expanding heart valve and delivery system offer flexible conduit and secure implantation under beating-heart conditions, and its stent valve positioning system has the unique ability to reposition at any time, which is important for precise placement of the implant.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1132992

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel